Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bolli

Showing results (391-400 of 1,466) with videos related to

Pageof 147
Sort By:
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1988
Modulation of left ventricular hypertrophy by dietary salt and inhibition of angiotensin converting enzymeD Fernandez, P Bolli, W Snedden, et al.
Pro-Fono : Revista De Atualizacao Cientifica|October 20, 2009
Intelligibility of phonological disorder assessed by three groups of judgesGabriele Donicht, Karina Carlesso Pagliarin, Helena Bolli Mota, et al.
Cardiovascular Research|March 1, 1985
Influence of alpha-adrenergic blockade on platelet-mediated thrombosis in stenosed canine coronary arteriesR Bolli, T A Brandon, M L Mace, et al.
Circulation Research|August 19, 2000
Circulation research Editors' yearly report: 1999-2000Marban, Bolli, Breitwieser, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2001
An essential role of the JAK-STAT pathway in ischemic preconditioningY T Xuan, Y Guo, H Han, et al.
Journal of Molecular and Cellular Cardiology|April 12, 2002
Expression of activated PKC epsilon (PKC epsilon) protects the ischemic heart, without attenuating ischemic H(+) productionHeather R Cross, Elizabeth Murphy, Roberto Bolli, et al.
Circulation|June 3, 1997
Preconditioning of human myocardium with adenosine during coronary angioplastyM A Leesar, M Stoddard, M Ahmed, et al.
Diabetes, Obesity & Metabolism|November 3, 2025
Importance of targeting post-prandial hyperglycaemia to achieve HbA1c goals in insulin glargine-treated subphenotypes of type 2 diabetesWolfgang Landgraf, David R Owens, Brian M Frier, et al.
Circulation Research|October 26, 2018
Introduction to Cardiovascular Aging CompendiumA J Marian, Aruni Bhatnagar, Roberto Bolli, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 15, 2024
Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc AnalysisWolfgang Landgraf, David R Owens, Brian M Frier, et al.
Pageof 147

Showing results (391-400 of 1,466) with videos related to

Sort By:
Pageof 147
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1988
Modulation of left ventricular hypertrophy by dietary salt and inhibition of angiotensin converting enzymeD Fernandez, P Bolli, W Snedden, et al.
Pro-Fono : Revista De Atualizacao Cientifica|October 20, 2009
Intelligibility of phonological disorder assessed by three groups of judgesGabriele Donicht, Karina Carlesso Pagliarin, Helena Bolli Mota, et al.
Cardiovascular Research|March 1, 1985
Influence of alpha-adrenergic blockade on platelet-mediated thrombosis in stenosed canine coronary arteriesR Bolli, T A Brandon, M L Mace, et al.
Circulation Research|August 19, 2000
Circulation research Editors' yearly report: 1999-2000Marban, Bolli, Breitwieser, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2001
An essential role of the JAK-STAT pathway in ischemic preconditioningY T Xuan, Y Guo, H Han, et al.
Journal of Molecular and Cellular Cardiology|April 12, 2002
Expression of activated PKC epsilon (PKC epsilon) protects the ischemic heart, without attenuating ischemic H(+) productionHeather R Cross, Elizabeth Murphy, Roberto Bolli, et al.
Circulation|June 3, 1997
Preconditioning of human myocardium with adenosine during coronary angioplastyM A Leesar, M Stoddard, M Ahmed, et al.
Diabetes, Obesity & Metabolism|November 3, 2025
Importance of targeting post-prandial hyperglycaemia to achieve HbA1c goals in insulin glargine-treated subphenotypes of type 2 diabetesWolfgang Landgraf, David R Owens, Brian M Frier, et al.
Circulation Research|October 26, 2018
Introduction to Cardiovascular Aging CompendiumA J Marian, Aruni Bhatnagar, Roberto Bolli, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 15, 2024
Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc AnalysisWolfgang Landgraf, David R Owens, Brian M Frier, et al.
Pageof 147